The effect of soybean oil refuse powder used as vehicle on the absorption of oxolinic acid in chickens under fasting and nonfasting conditions and the correlation with in vitro dissolution

Journal of Veterinary Pharmacology and Therapeutics

Volumn 24, Issue 5, 2001, Pages 333-341

  Hamamoto, K ^a   Koike, R ^a   Machida, Y ^b  

^a NATIONAL VETERINARY ASSAY LABORATORY   (Japan)

^b HOSHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG VEHICLE; OXOLINIC ACID; SOYBEAN OIL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHICKEN; CONTROLLED STUDY; CORRELATION FUNCTION; DIET RESTRICTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; NONHUMAN; PH; POWDER; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; AREA UNDER CURVE; CHICKENS; FASTING; FEMALE; HALF-LIFE; HYDROGEN-ION CONCENTRATION; INTESTINAL ABSORPTION; METABOLIC CLEARANCE RATE; OXOLINIC ACID; POWDERS; SOYBEAN OIL; THERAPEUTIC EQUIVALENCY;

ANIMALIA; GALLUS GALLUS; GLYCINE MAX;

EID: 0034777251     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.2001.00347.x     Document Type: Article

References (53)

1. New results on an in vitro model for study of the influence of fatty meals on the bioavailability of theophylline controlled-release formulations
2. Theoretical basis for a biopharmaceutic drug classification: The correlation of in vitro drug product dissolution and in vivo bioavailability
3. Basic concept and rules of dissolution tests in Japanese pharmacopoeia
4. Bioequivalence: Performance of several measures of extent of absorption
5. Effect of citric and ascorbic acids on performance and intestinal pH of chicks
6. Effect of food on absorption of cefadroxil and cephalexin in dog
7. In vitro/in vivo correlation of prolonged release dosage forms containing siltiazem HCL
8. Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters
9. Zero-order release formulation of oxprenolol hydrochloride with swelling and erosion control
10. Review, dissolution testing as a prognostic tool for oral drug absorption: Immediate release dosage forms
11. Relevance of pH dependency on in vitro release of bromocriptine from a modified-release formulation
12. A new approach to modeling the relationship between in vitro and in vivo drug dissolution/absorption
13. Theophylline-controlled release preparations and fatty food: And in vitro study using the rotating dialysis cell method
14. In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms
15. Multiple-layer, direct-compression, controlled-release system: In vitro and in vivo evaluation
16. Effects of sarasaponin on digestion and passage rates in cattle fed medium to low concentrate
17. Rapid high-performance liquid chromatogrphic method for the determination of oxolinic acid in chicken plasma
18. Gastro- intestinal transit rate and bioavailability of powder and granules in chicken
19. Bioavailability of commercial preparations of oxolinic acid administration to chicken under fasting and non-fasting condition and its relation to their in vitro dissolution rates
20. Kinetics of absorption of a new once-a-day formulation of theophylline in the presence and absence of food
21. In vivo-in vitro correlation of a modified-release oral form of ketotifen: In vitro dissolution rate specification
22. Release and absorption characteristics of novel theophylline sustained-release formulation: In vitro-in vivo correlation
23. Estimation of drug absorption rates using a deconvolution method with nonequal sampling times
24. Power analysis of moment analysis parameter in bioequivalence tests
25. Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation
26. Comparison of simulated and actual plasma profiles of oxolinic acid in chickens-correlation between in vitro test and in vivo test
27. The cutoff time point of the partial area method for assessment of rate of absorption in bioequivalence studies
28. The bioinequivalence of carbamazepine tablets with a history of clinical failures
29. Influence of food on bioavailability of drugs
30. Estimation of the increase in solubility of drugs as function of bile salt concentration
31. Correlation of in vitro release rate and in vivo absorption characteristics of four chlorpheniramine maleate extended-release formulation
32. Oral bioavailability of sulfadiazine and trimethoprim in fed and fasted pigs
33. Bioavailability of oxytetracycline, tetracycline and chlortetracycline after oral administration to fed and fasted pigs
34. Bioavailability of spiramycin and lincomicin after oral administration to fed and fasted pigs
35. Digestion in the domestic fowl
36. Influence of dietary electrolytes on digestive tract pH and acid-base status of chicks
37. max with different dissolution rates
38. Aqueous solubility and dissolution rate does not adequately predict in vivo performance: A probe utilizing some N-acyloxymethyl phenytoin prodrugs
39. Bioavailability of sulfonamide suspensions. I: Dissolution profiles of sulfamethizole using paddle method
40. In vitro and in vivo characteristics of some commercial phenobarbital tablets
41. Studies on dissolution tests of soft gelatin capsules. V. Rotating dialysis cell method
42. Related articles, studies on dissolution tests for soft gelatin capsules by the rotating dialysis cell (RDC) method. IV. Preparation and evaluation of ibuprofen soft gelatin capsules
43. In-vitro/in-vivo correlation for extended release oral dosage forms
44. Bioavailability of tolazamide from tablets: Comparison of in vitro and in vivo results
45. Changes in gastrointestinal pH associated with fasting in the laying hen
46. The effect of food on drug bio#132;availability
47. Statistical moments in pharmacokinetics
48. In vivo-in vitro correlations with a commercial dissolution simulator. I: Methanamine, nitrofurantoin, and chlorothiazide
49. In vivo-in vitro correlations with a commercial dissolution simulator II: Papaverine, phenytoin, and sulfisoxazole